Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IL/Joliet
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Joliet, IL

Studies commonly pay $75 to $4,500 per completed study

522 clinical trials are currently recruiting participants within 30 miles of Joliet. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

522studies recruiting
9+research centers nearby
7condition categories
Live from the NIH registry

Studies recruiting near Joliet right now

Top 25 of 522 recruiting studies, sorted by proximity — each links to its official registry page

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications Phase 3 Interventional 115 participants sought
Loyola University Medical Center (Adults and Pediatrics) — Maywood, Illinois (29.5 mi) · Sponsor: Pierre Fabre Medicament
See eligibility & contact on ClinicalTrials.gov (NCT03394365)

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer, c-MET Phase 3 Interventional 768 participants sought
Edward-Elmhurst Cancer Center /ID# 238552 — Elmhurst, Illinois (28.4 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT04928846)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought
Edward Hospital/Cancer Center — Naperville, Illinois (18.5 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05946213)

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Phase 3 Interventional 450 participants sought
Sl0044 50717 — Willowbrook, Illinois (20.6 mi) · Sponsor: UCB Biopharma SRL
See eligibility & contact on ClinicalTrials.gov (NCT06617325)

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease N/A Observational 3,000 participants sought
Loyola University Health System — Maywood, Illinois (29.5 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT01915511)

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Pancreatic Cancer Phase 2 Interventional 60 participants sought
Northwestern Medicine Chicago Proton Center — Warrenville, Illinois (20.7 mi) · Sponsor: Proton Collaborative Group
See eligibility & contact on ClinicalTrials.gov (NCT02598349)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
UC Comprehensive Cancer Center at Silver Cross — New Lenox, Illinois (9.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
University Retina and Macula Associates, PC — Lemont, Illinois (13.2 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

Recurrent Glioblastoma, IDH-Wildtype, Recurrent MGMT-Methylated Glioblastoma Phase 1, Phase 2 Interventional 97 participants sought
University of Chicago Medicine-Orland Park — Orland Park, Illinois (17.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05432804)

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Phase 3 Interventional 428 participants sought
Northwestern Medicine Cancer Center Warrenville — Warrenville, Illinois (20.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05646316)

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Heart Failure Phase 3 Interventional 1,500 participants sought
CON-10025, Naperville, IL — Naperville, Illinois (18.5 mi) · Sponsor: Colorado Prevention Center
See eligibility & contact on ClinicalTrials.gov (NCT06024746)

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis, Ulcerative Colitis Chronic Phase 2 Interventional 143 participants sought
Avicenna Clinical Research - SW Gastroenterology — Oak Lawn, Illinois (24.2 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06598943)

Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor

Perinatal Decision Making N/A Interventional 2,200 participants sought
Endeavor Health Edward Hospital — Naperville, Illinois (18.5 mi) · Sponsor: Endeavor Health
See eligibility & contact on ClinicalTrials.gov (NCT06828406)

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Complex Regional Pain Syndrome Type I Phase 3 Interventional 270 participants sought
Ambros Clinical Trial Site — Orland Park, Illinois (17.1 mi) · Sponsor: Ambros Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07210515)

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

Diabetic Retinopathy Phase 2, Phase 3 Interventional 576 participants sought
University Retina - Oak Forest /ID# 283021 — Oak Forest, Illinois (21.8 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT07592273)

Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction

Heart Failure With Preserved Ejection Fraction Phase 3 Interventional 2,000 participants sought
Fox Valley Clinical Research Center, LLC — Aurora, Illinois (18.9 mi) · Sponsor: Uppsala University
See eligibility & contact on ClinicalTrials.gov (NCT02901184)

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 2 Interventional 99 participants sought
Northwestern Medicine Cancer Center Warrenville — Warrenville, Illinois (20.7 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04302025)

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Non-Small Cell Lung Cancer Phase 3 Interventional 675 participants sought
Research Site — Hinsdale, Illinois (22.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06357533)

Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathic Pain Phase 2 Interventional 300 participants sought
Healthcare Research Network - Flossmoor IL — Flossmoor, Illinois (24.1 mi) · Sponsor: Vertex Pharmaceuticals Incorporated
See eligibility & contact on ClinicalTrials.gov (NCT06619860)

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer Phase 3 Interventional 600 participants sought
Hope and Healing Cancer Services — Hinsdale, Illinois (22.4 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06793215)

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

Non-obstructive Hypertrophic Cardiomyopathy Phase 2 Interventional 165 participants sought
Imbria Investigational Site — Oak Lawn, Illinois (24.2 mi) · Sponsor: Imbria Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07023614)
Actively enrolling

Studies you may be able to join near Joliet

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Joliet

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

JCCR (Joliet Center for Clinical Research)

★ 4.2 (115 reviews)
210 N Hammes Ave #205, Joliet, IL 60435
(815) 729-7790
"Buena atencion al cliente me ayudaron a encontrar buenos propuestas de pago"
— Alex Gonzalez, 5★

Medworks Occupational Health

★ 4.1
815 Campus Dr, Joliet, IL 60435
(815) 744-0808
"Very friendly place the physical got done very quickly"
— Matt S, 5★

Avicenna Clinical Research

★ 4.9
9912 SW Hwy, Oak Lawn, IL 60453
(708) 575-5535
"Joy Jibunoh was very professional and knowledgeable!! Showed great patience when asking questions with clarity!"
— tony torres, 5★

Chicago Clinical Research Institute, Inc.

★ 5.0
611 W Roosevelt Rd, Chicago, IL 60607
(312) 823-6800

Bioluminux Clinical Research Illinois

Brom Medical Center, 720 Brom Dr Ste 205, Naperville, IL 60540
(331) 401-5117

DM Clinical Research—Chicago

★ 4.3
1111 Superior St #306, Melrose Park, IL 60160
(708) 616-1313
"INCREDIBLE PPL ACROSS THE BOARD......A FEEL GOOD EXPERIENCE IN MELROSE PARK ON SUPERIOR.......I JUST COMPLETED MY COVID PROGRAM MAY 12 2026 . THIS…"
— Warren Roesner, 5★

Chicago Medical Research, LLC

★ 4.9
3330 W 177th St, Hazel Crest, IL 60429
(708) 798-8522
"Great medical research center."
— Michelle Mackey, 5★

Lemah Creek Clinical Research

17W715 Butterfield Rd E, Oakbrook Terrace, IL 60181
(708) 274-1577

Axis Clinical Research

★ 5.0
10031 Roosevelt Rd, Westchester, IL 60154
(708) 441-3701

Clinical trials in Joliet: what's recruiting

The Joliet area currently has 522 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Joliet, the most active research areas are:

  • Cancer & Oncology11 studies
  • Heart & Vascular4 studies
  • Immune & Skin2 studies
  • Diabetes & Metabolism2 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Joliet, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Joliet

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Joliet participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Joliet pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Joliet?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Joliet, IL?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Joliet typically complete one or two studies per year.

Paid clinical trials near Joliet

Other metros within reach

Naperville, IL2,359 Aurora, IL621 Chicago, IL2,443 Round Lake Beach, IL470 Rockford, IL112 Champaign, IL172 Milwaukee, WI698 Peoria, IL216

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Joliet Chronic Kidney Disease (HealthMatch) in Joliet Bladder Issues Due To Spinal Cord Injury in Joliet All conditions

More of IL

Chicago2,443 Naperville2,359 Aurora621 Round Lake Beach470 Peoria216 Springfield184 Champaign172 Rockford112

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts